A Grapefruit Feeding Trial in Healthy, Overweight Adults

Sponsor
University of Arizona (Other)
Overall Status
Completed
CT.gov ID
NCT01452841
Collaborator
Texas A&M University (Other)
85
1
2
20
4.3

Study Details

Study Description

Brief Summary

Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, though there is some evidence of health promotional effects regarding blood pressure and lipid profiles. The aims of this randomized controlled trial are to determine the role of grapefruit in:

  1. Reducing weight

  2. Reducing blood pressure

  3. Reducing inflammation

  4. Improving the lipid profile.

The investigators hypothesize that six weeks of daily consumption of grapefruit will reduce weight, blood pressure, and inflammation while improving the lipid profile in overweight, healthy adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Grapefruit
  • Other: Control
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
85 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Efficiency of Daily Grapefruit Exposure in Reducing Body Weight and Inflammatory Markers
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Apr 1, 2011
Actual Study Completion Date :
Apr 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Grapefruit Consumption

Other: Grapefruit
1.5 Rio Red Grapefruit consumed daily for 6 weeks

Active Comparator: Control

Other: Control
Participants followed a diet low in bioactive rich fruits and vegetables and avoided citrus for six weeks

Outcome Measures

Primary Outcome Measures

  1. Weight reduction [6 weeks]

    Participants consumed 1/2 grapefruit before each meal (1.5 grapefruit per day) for six weeks. Weight was measured before and after grapefruit consumption to assess weight change. Weight change was considered statistically significant at p<0.05.

Secondary Outcome Measures

  1. Blood pressure reduction [6 weeks]

    Previous studies in animals and humans consuming citrus have resulted in reductions in blood pressure, though no direct effect of grapefruit has ever been demonstrated. Blood pressure was measured at baseline and after the 6 week intervention period (consuming either the control diet or supplementing the diet with 1/2 grapefruit before each meal).

  2. Lipid Profile Improvements [6 weeks]

    Previous studies in humans and animal models consuming grapefruit or grapefruit bioactives have shown reductions in triglycerides, LDL, and total cholesterol and increases in circulating HDL. These parameters were measured via a common point-of-care system, LDX Cholestech. Lipids were measured at baseline and after the 6 week intervention period (consuming either the control diet or supplementing the diet with 1/2 grapefruit before each meal).

  3. Reductions in markers of chronic inflammation [6 weeks]

    Markers of chronic inflammation, which are also associated with endothelial dysfunction and heart disease, like tumor necrosis factor alpha (TNFalpha), interleukin-1beta (IL-1beta), and soluble vascular cellular adhesion molecule-1 (sV-CAM1) were measured. Inflammatory markers were measured at baseline and after the 6 week intervention period (consuming either the control diet or supplementing the diet with 1/2 grapefruit before each meal).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults, men and premenopausal women

  • BMI: 25-45 kg/m2

  • Willing to maintain current exercise regimen (not to exceed 10 hours/week)

  • Willing to follow a diet low in bioactive rich fruits and vegetables and with no citrus

Exclusion Criteria:
  • History of chronic disease

  • Metabolic disease

  • Inflammatory disease

  • High cholesterol (>225 mg/dL)

  • Smoker

  • Taking medications metabolized by the Cytochrome P450 3A enzyme

  • History of alcohol or drug abuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Arizona Tucson Arizona United States 85721

Sponsors and Collaborators

  • University of Arizona
  • Texas A&M University

Investigators

  • Principal Investigator: Cynthia Thomson, PhD, RD, University of Arizona

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Arizona
ClinicalTrials.gov Identifier:
NCT01452841
Other Study ID Numbers:
  • 09-0695-02
First Posted:
Oct 17, 2011
Last Update Posted:
Oct 17, 2011
Last Verified:
Oct 1, 2011
Keywords provided by University of Arizona
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 17, 2011